Antibody Product definition

Antibody Product means any product comprising an Antibody or Genetic Material encoding an Antibody wherein, in respect of each Antibody Product, said Genetic Material does not encode multiple Antibodies.

Antibody Product means any product containing an Antibody.

Antibody Product means any composition of matter or article of manufacture consisting essentially of an Antibody alone or integrally associated with a composition of matter or article of manufacture (including without limitation conjugates bound to a toxin, label or other moiety) providing therapeutic, half-life, safety or other advantages to the Antibody. For the avoidance of doubt, Antibody Product does not include gene therapy products, Fc fusion proteins lacking antibody variable domains or viral conjugates.

Examples of Antibody Product in a sentence

• Guidance for Industry for the Submission of Chemistry, Manufacturing, and Controls Information for a Therapeutic Recombinant DNA-Derived Product or a Monoclonal Antibody Product for In Vivo Use, August 1996.

• This Agreement shall terminate in relation to such Antibody Product (as well as all Subsequent Products), but remain in full force and effect with respect to any Antibody Product which has previously been subject to the procedures set out in Article 3.4(a) and which Celltech shall not have previously exercised its opt-out right.

• With respect to each Antibody Product receiving Regulatory Approval for Commercialisation, the Manufacturing Lead shall be responsible for [*] Antibody Raw Material for commercial use in the Territory (in quantities as forecast in the Commercialisation Plan and with specifications set forth in the Regulatory Approval of such Antibody Raw Material).

• Each Party agrees to conduct its Research activities and Development activities in compliance with all laws, regulations and guidelines that are applicable to the particular stage of Research or Development for the Antibody Product, including, GLP, GCP and GMP, of the relevant jurisdiction as the same may be amended from time to time.

• However, Celltech’s opt out right shall apply to any other Antibody Product that Amgen proposes to advance or advances to Late Stage Development, and Articles 3.4(a) and (b) shall apply mutatis mutandis to all such Antibody Products.

More Definitions of Antibody Product

Antibody Product means any Antibody that (a) includes a complementarity determining region derived from an Antibody among the Deliverables, or derived from an Antibody provided in tangible form to Client pursuant to any Related Agreement, or panned by Client from Distributed Bio’s antibody library provided pursuant to the Library Agreement, and (b) is included in Assigned Antibody Rights (or such defined term or the equivalent thereof in any Related Agreement), including fragments, variants, modifications and derivatives thereof.

Antibody Product means any pharmaceutical product having an Antibody as an active ingredient.

Antibody Product means any composition or formulation containing or comprising one or more Antibodies, including, by way of clarification, (a) * one or more of such * with respect to the * of such Antibodies, and (b) * with respect to the * of such Antibodies (or a * of such * containing that portion of such * , for the diagnosis, prophylaxis or treatment of human diseases or conditions.

Antibody Product means a pharmaceutical preparation that contains one or more ADDL Antibodies for application in the Therapeutic Field and is (i) for administration to human patients in a Clinical Trial, or (ii) for sale by prescription, over the counter, or any other method. Notwithstanding the foregoing, a pharmaceutical preparation shall not be considered an Antibody Product if it is a Vaccine Product, is intended for use in the Diagnostic Field, or it contains a Small Molecule.

Antibody Product means a whole antibody, or a fragment thereof, that binds to a particular Target Antigen and is derived from Abgenix Technology pursuant to the Research Plan.

Antibody Product means any composition or formulation containing or comprising one or more Antibodies in any format for the prognosis, diagnosis, prophylaxis or treatment of human diseases or conditions or for use as a research reagent.

Antibody Product means a Product which is an antibody (monoclonal or polyclonal) or fragments or constructs thereof in the Merck Field which is potentially useful for the treatment or prevention of a disease or disorder in humans. 1.3 "Antisense" shall mean inhibiting or preventing in vivo expression in a human or animal of a gene product by use of an oligonucleotide or modified oligonucleotide which binds to RNA or DNA to prevent and/or impair expression of the gene product. 1.4 "Blocking Claim" shall mean a claim under any patent application or granted patent anywhere in the world which generically but not specifically covers (i) any and all compounds (and/or the use thereof) which interact with or prevent interaction with a specified Target and/or (ii) any and all antibodies (and/or the use thereof) against a specific Target or Therapeutic Protein. The following are examples of "blocking claims": (1) a compound which interacts with receptor X; (2) a compound which prevents binding between receptor X and its ligand, (3) a process for activating receptor X, comprising: contacting receptor X with a compound which binds thereto and activates the receptor; (4) a process for preventing activation of receptor X comprising: contacting receptor X with a compound which prevents binding between receptor X and its ligand. 1.5 "Bioinformatics" shall mean computer software and know-how useful for the analysis, comparison, and curation of human nucleic acid and protein sequences, and information related to such sequences; and software for the construction and maintenance of databases for the compilation of such sequences and their associated information; each as developed through the end of the Initial Research Term. Bioinformatics shall include software for the prediction of the three-dimensional structure of proteins from primary sequence information but Bioinformatics shall not include software for rational drug design based on such three-dimensional structure. 1.6 "Collaboration Agreement"shall mean the Collaboration Agreement entered into between SB and HGS effective as of May 19, 1993, as amended and/or superseded from time to time. 1.7 "Collaboration Partner Agreement" shall mean an agreement between or among SB and/or HGS and (1) Synthelabo substantially in accordance with a memorandum of intent dated March 11, 1996; (2) SP substantially in accordance with a memorandum of intent dated April 21, 1996; (3) Takeda substantially in accordance with the SB/Takeda Collaboration and L...